NEW YORK (GenomeWeb) – Members of the PsychENCODE Consortium have explored the role of non-coding risk variants in regulatory processes that influence brain function and the development of neuropsychiatric conditions such schizophrenia, bipolar disorder, or autism spectrum disorder (ASD) — results they reported in a collection of papers published in Science, Science Translational Medicine, and Science Advances.